Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Spectranetics Cp T (SPNC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 1,172,768
  • Shares Outstanding, K 43,760
  • Annual Sales, $ 270,820 K
  • Annual Income, $ -58,120 K
  • 36-Month Beta 1.61
  • Price/Sales 4.40
  • Price/Cash Flow 0.00
  • Price/Book 19.69

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.70 +0.37%
on 05/26/17
30.15 -11.11%
on 05/02/17
-2.45 (-8.38%)
since 04/26/17
3-Month
26.70 +0.37%
on 05/26/17
30.15 -11.11%
on 05/02/17
-1.25 (-4.46%)
since 02/24/17
52-Week
16.83 +59.24%
on 06/28/16
30.15 -11.11%
on 05/02/17
+8.69 (+47.98%)
since 05/26/16

Most Recent Stories

More News
Healthcare Veteran John Fletcher Joins MRI Interventions' Board of Directors

MRI Interventions, Inc. (OTCQB:MRIC) is pleased to announce that John Fletcher has been appointed to MRI Interventions' Board of Directors. Mr. Fletcher, founder and managing partner of Fletcher Spaght,...

SPNC : 26.80 (-1.47%)
MRICD : 7.0500 (-2.08%)
ACLS : 22.35 (+1.59%)
MRIC : 3.2000 (-39.62%)
Spectranetics Reports First Quarter 2017 Revenue of $69.7 million

The Spectranetics Corporation (NASDAQ:SPNC) ("the Company") today reported financial results for the three months ended March 31, 2017. Highlights of the quarter, all compared with the three months ended...

SPNC : 26.80 (-1.47%)
23.1% Return Seen to Date on SmarTrend Spectranetics Call (SPNC)

SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on November 11th, 2016 at $23.72. In approximately 6 months, Spectranetics has returned 23.08% as of today's recent price of $29.20.

SPNC : 26.80 (-1.47%)
Spectranetics Announces First Quarter 2017 Conference Call

The Spectranetics Corporation (NASDAQ:SPNC), today announced that the Company will release first quarter 2017 financial results on Thursday, April 27, 2017. Company management will host a conference call...

SPNC : 26.80 (-1.47%)
Spectranetics Up 18.9% Since SmarTrend Uptrend Call (SPNC)

SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on November 11th, 2016 at $23.72. In approximately 5 months, Spectranetics has returned 18.86% as of today's recent price of $28.20.

SPNC : 26.80 (-1.47%)
AtriCure Names Two New Members to its Board of Directors

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that Regina Groves...

SPNC : 26.80 (-1.47%)
PJC : 59.20 (-0.84%)
ATRC : 20.71 (-1.71%)
MDT : 85.09 (-0.57%)
Spectranetics Reports Fourth Quarter 2016 Revenue of $71.9 million

The Spectranetics Corporation (NASDAQ:SPNC) today reported financial results for the three months and year ended December 31, 2016. Highlights of the quarter, all compared with the three months ended...

SPNC : 26.80 (-1.47%)
Spectranetics Names Scott Hutton as General Manager, Vascular Intervention

The Spectranetics Corporation (NASDAQ:SPNC), ("the Company") today announced that Scott Hutton has been named General Manager, Vascular Intervention, effective January 23, 2017. In this role, Mr. Hutton...

SPNC : 26.80 (-1.47%)
MDT : 85.09 (-0.57%)
Research Reports Initiation on Medical Equipment Stocks -- Lantheus, Nevro, Steris, and Spectranetics

Ahead of today's session, Stock-Callers.com presents these four equities in the Medical Appliances and Equipment space for review: Lantheus Holdings Inc. (NASDAQ: LNTH), Nevro Corp. (NYSE: NVRO), Steris...

NVRO : 73.84 (-0.31%)
SPNC : 26.80 (-1.47%)
LNTH : 17.05 (+0.29%)
STE : 77.10 (-0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Spectranetics Corp. is a medical device company engaged in the development, manufacturing, marketing and distribution of its technology for interventional cardiovascular therapy. The Company's CVX-300 excimer laser system is the only excimer laser system approved by the FDA for multiple cardiovascular...

See More

Support & Resistance

2nd Resistance Point 27.40
1st Resistance Point 27.10
Last Price 26.80
1st Support Level 26.60
2nd Support Level 26.40

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.